If a bacteria is sensitive to penicillins (antibiotics), is it also sensitive to all cephalosporins (antibiotics)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

No, a bacterium that is sensitive to penicillins is not necessarily sensitive to all cephalosporins. While both penicillins and cephalosporins are beta-lactam antibiotics that work by inhibiting bacterial cell wall synthesis, there are important differences in their spectrum of activity and resistance patterns. Some bacteria have developed mechanisms to resist specific beta-lactams while remaining susceptible to others. For example, certain strains of Staphylococcus aureus produce beta-lactamase enzymes that can inactivate penicillins but may not affect some cephalosporins, particularly later generations (like cefepime or ceftaroline) 1. Conversely, some Gram-negative bacteria may have porin channel mutations that prevent certain cephalosporins from entering the cell while still allowing penicillin entry.

When selecting antibiotics, it's essential to consider the specific organism identified, its susceptibility testing results, the generation of cephalosporin being considered, and the site of infection. This is why antibiotic susceptibility testing is crucial for guiding appropriate antibiotic therapy rather than making assumptions based on cross-sensitivity between antibiotic classes. The risk of cross-reactivity between penicillins and cephalosporins is estimated to be around 2-5% 1, and is higher in those with true penicillin allergy. However, the degree of cross-reactivity is higher between penicillins and first-generation cephalosporins but is negligible with the second- and third-generation cephalosporins 1.

Key points to consider:

  • The chemical structure of the cephalosporin determines the risk of cross-reactivity between specific agents 1
  • Cefdinir, cefuroxime, cefpodoxime, and ceftriaxone are highly unlikely to be associated with cross-reactivity with penicillin 1
  • Antibiotic susceptibility testing is crucial for guiding appropriate antibiotic therapy rather than making assumptions based on cross-sensitivity between antibiotic classes
  • The specific organism identified, its susceptibility testing results, the generation of cephalosporin being considered, and the site of infection should all be taken into account when selecting antibiotics.

From the FDA Drug Label

Methicillin-resistant staphylococci are uniformly resistant to cefazolin, and many strains of enterococci are resistant Most strains of indole positive Proteus (Proteus vulgaris), Enterobacter spp., Morganella morganii, Providencia rettgeri, Serratia spp., and Pseudomonas spp. are resistant to cefazolin.

Sensitivity to penicillins does not guarantee sensitivity to all cephalosporins.

  • The FDA drug label for cefazolin 2 indicates that some bacteria resistant to methicillin and many strains of enterococci are also resistant to cefazolin, a type of cephalosporin.
  • Additionally, the label states that most strains of certain gram-negative bacteria, such as Pseudomonas spp., are resistant to cefazolin.
  • The label for ceftriaxone 3 also notes that patients with previous hypersensitivity reactions to penicillin and other beta-lactam antibacterial agents may be at greater risk of hypersensitivity to ceftriaxone, suggesting that sensitivity to penicillins does not necessarily imply sensitivity to all cephalosporins. The FDA drug label does not provide a direct answer to the question of whether sensitivity to penicillins guarantees sensitivity to all cephalosporins, but it does suggest that this is not the case.

From the Research

Bacterial Sensitivity to Penicillins and Cephalosporins

  • Bacteria that are sensitive to penicillins may not necessarily be sensitive to all cephalosporins, as the mechanisms of resistance and the spectrum of activity can vary between these two classes of antibiotics 4, 5.
  • Cephalosporins are classified into different generations based on their spectrum of activity against gram-negative bacteria, and their effectiveness against gram-positive bacteria and anaerobes can also differ 4.
  • The cross-reactivity between penicillins and cephalosporins is generally low, especially for later-generation cephalosporins, which means that bacteria sensitive to penicillins may still be resistant to certain cephalosporins 6, 7.

Factors Influencing Bacterial Sensitivity

  • The sensitivity of bacteria to cephalosporins can be influenced by various factors, including the modification of penicillin-binding proteins, the production of beta-lactamases, and the permeability of the bacterial cell membrane 5.
  • The reliability of using one cephalosporin to predict susceptibility to another can vary, and studies have shown that ceftriaxone susceptibility can predict susceptibility to certain oral cephalosporins, but not all 8.

Clinical Implications

  • When treating bacterial infections, it is essential to consider the specific sensitivity profile of the bacteria to different antibiotics, including penicillins and cephalosporins 6, 7.
  • In cases where a patient has a reported allergy to penicillins, cephalosporins can still be considered as a treatment option, but careful evaluation of the patient's allergy history and potential cross-reactivity is necessary 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cephalosporins: rationale for clinical use.

American family physician, 1991

Research

Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.